Skip to main content
Research project

Treatment outcome study on using herbal medicine in acute respiratory tract infections

Project overview

Acute respiratory tract infections are common globally, resulting in a significant rise in antibiotic usage. This study investigates the use of various treatments and their impact on antibiotic usage and patient-reported clinical recovery in Chinese adults with acute cough. An online survey was conducted to recruit individuals who recently had a cough. Data on sociodemographic factors, clinical characteristics, received treatments, and perceived changes in symptoms were collected. Factors influencing antibiotic avoidance and symptom improvement were examined.

A total of 22,787 Chinese adults with recent acute cough participated in the survey, covering all 34 province-level administrative units in China. Most respondents were male (68.0%), young (89.4%, aged 18–45), and educated to university/degree or postgraduate level (44.6%). The median cough severity was reported as 6/10 on a numerical rating scale. Approximately 46.4% of participants reported antibiotic usage, with 93.1% for presumed upper respiratory tract infections (URTIs). Pharmacies were the most common source of antibiotics (48.8%). A lower percentage of patients used antibiotics after traditional Chinese herbal medicine (CHM) treatment (14.9%), compared to those who used home remedies (18.0%) or allopathic non-antibiotic medication (25.0%). Antibiotics, allopathic non-antibiotic medications, CHM, and home remedies were all perceived as beneficial in relieving cough symptoms.

Chinese adults utilise a diverse range of treatments for acute cough. Patient-reported clinical recovery was similar across different treatment modalities. There appears to be a considerable proportion of inappropriate antibiotic use for treating simple acute cough. Given that the majority of respondents did not use antibiotics as a first-line treatment and CHM usage was associated with cough symptom relief and reduced antibiotic consumption, this presents a significant opportunity for prudent antibiotic stewardship in China.

Staff

Lead researcher

Dr Xiao-Yang (Mio) Hu

Research Fellow

Research interests

  • Evidence-based Integrative and Complementary Medicine
  • Antimicrobial Stewardship
  • Mixed Methods Research
Connect with Xiao-Yang (Mio)

Research outputs

Ruyu Xia, Xiaoyang Hu, Michael Moore, Beth Stuart, Lingzi Wen, Bertrand Graz, Jianping Liu, Merlin Willcox & Yutong Fei, 2023, European Journal of Integrative Medicine, 62
Type: article
Xinyan Jin, Leqin Xu, Chunli Lu, Xue Xue, Xuehan Liu, Yuzhen Zhou, Xiaoyang Hu, Jianping Liu & Xiaohua Pei, 2023, European Journal of Integrative Medicine, 61
Type: article
Xiao-Yang Hu, Ru-Yu Xia, Michael Moore, Beth Stuart, Ling-Zi Wen, Bertrand Graz, Lily Lai, Jian-Ping Liu, Yu-Tong Fei & Merlin Willcox, 2022, Integrative Medicine Research, 12(1)
Type: article
Chun-Li Lu, Ruo-Xiang Zheng, Xue Xue, Xiao-Wen Zhang, Xue-Han Liu, Xin-Yan Jin, Feng-Lan Pu, Hui-Di Lan, Min Fang, Ling-Yao Kong, Merlin Willcox, Bertrand Graz, Joelle Houriet, Xiao-Yang Hu & Jian-Ping Liu, 2021, Integrative Medicine Research, 10
Type: article